ICBI Companies
Current Companies
Anagin
Developing new therapies for pain and traumatic brain injury.
Atelerix Life Sciences / Airbase Breathing Company
Developing new therapies for pain and traumatic brain injury to be used in the community, in the hospital and in response to the threat of Opioid Induced Respiratory Depression in terrorism.
Ciconia
Ciconia Biosciences, a preclinical Partner Research Organization (PtRO), is dedicated to expediting the discovery of next generation therapies for diverse health disorders.
Degrome Therapeutics
Degrome Therapeutics, Inc. is specialized in discovery and development of small molecule degraders of neurodegenerative disease-causing proteins as the first-in-class drugs. The company was founded by Drs. Anita Bellail and Chunhai Hao in 2023 in Indiana after they identified hit compounds as Alzheimer Precursor Protein (APP) degrader.
E&E BioClub
E&E BioClub focuses on facilitating the advancement of biotherapeutics into the clinical stage by developing cost-effective and scalable manufacturing processes.
HB Therapeutics
Discovery and development of small molecule protein degraders as new anticancer drugs.
Health Smart Technologies
Health Smart Technologies, Inc. is an Indiana University based company that merges Engineering and Rehabilitation expertise to develop Smart technology advancing manual therapy.
Monon Bioventures
Assisting world-class investigators to navigate the early stage challenges of translating their research into the clinic.
Scioto Biosciences
Developing innovative therapies devoted to having a significant impact on the delivery of microbiome therapeutics.
Skolnick & Company
Stephen Skolnick and Company is harnessing the power of the human gut microbiome to produce new and innovative foods for human health.
Simmaron Research
Simmaron Research is working to imiprove the diagnosis, treatment and medical understanding of Myalgic Encephalomyellitis/Chronic Fatique Syndrome (ME/CFS) and other neuroimmune diseases.
Vasculonics
Treatment of vascular complications.
Graduated Companies
Femtera
Leading discovery & clinical diagnostic
applications of novel metabolite biomarkers for the detection of catastrophic diseases.
Genezen
Offers contract viral vector production, transduced cell manufacturing, and clinical trial testing services by leveraging the expertise of the nations's leading academic vector production and research laboratories.
Early is Good
Co-Founded by Dr. Thakshila Liyanage and Asel Liyanage, Early is Good is a cancer diagnostic company taking aim at first creating a simple urine test (BCDx-biomarker detection) for bladder cancer.